Get notified when COSM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Going Concern (unchanged) — Filing states that conditions raise substantial doubt about the company's ability to continue as a going concern. The same disclosure appeared in the baseline filing.
revenue $17.9M, net income -$2.8M. Cosmos Health flags going-concern doubt as loss widens despite 31% revenue growth
Filed May 20, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~2 min read
Key Changes
-
high
Gross margin collapsed to 7.7% from 15.0% despite 31% revenue growth, driven by shift to lower-margin wholesale distribution and a $17.9M revenue reversal for a customer with collection issues. Net loss widened to $2.8M from $818k.
MD&A: Gross Margin & Profitability verify on EDGAR → -
high
Operating cash outflow widened to $1.1M from $186k, reversing prior-year improvement trend. Company deployed $1.1M to purchase crypto assets (ETH and BTC), then recognized $442k mark-to-market loss on those holdings in the same quarter.
MD&A: Cash Flow & Digital Assets verify on EDGAR → -
high
Pharmalink UAE distribution agreement (signed June 2024) has generated only the initial 130k-unit order with no follow-on orders executed as of May 2026, despite expectations for 500k units in year one and 3M over five years.
MD&A: Pharmalink Agreement verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade COSM commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 26, 2026 · How we verify